SUPN fund manager activity
Supernus Pharmaceuticals, Inc · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q1 2015 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Jeremy Grantham - GMO | New | 4,241 | $210,778 | 0.00% | Feb 17, 2026 |
| Third Avenue Management | No change | 189,493 | $9,417,802 | 1.71% | Feb 12, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Sold out | — | — | 0.00% | Nov 14, 2025 |
| Third Avenue Management | No change | 189,493 | $9,103,244 | 1.71% | Nov 14, 2025 |